[Anti-Xa activity during administration of low-molecular weight heparin in the prevention of postoperative thromboembolic complications].
The authors evaluate the follow-up of the anti-Xa level during the prophylactic administration of two different low molecular heparins (enoxaparin, reviparin) in 40 patients with a planned resection of the large intestine, resection of the pancreas, laparoscopic cholecystectomy and laparotomic cholecystectomy. The assessed amounts of anti-Xa did not reach recommended levels even during the perioperative period. The selection of the preparation and the extent of the operation did not influence the anti-Xa levels.
Gürlich
R
R
I. chirurgická klinika 1. LF UK a VFN Praha.
Salaj
P
P
Hrachovinová
I
I
D000328:Adult; D017984:Enoxaparin / Q000627:therapeutic use*; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D017984:Enoxaparin; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; C094240:reviparin